Sarepta timeline delayed on muscular dystrophy drug By: CNBC.com News October 27, 2014 at 07:36 AM EDT The roller coaster ride for Sarepta continues, as it's likely to file for approval of its muscular dystrophy drug in mid-2015. Read More >> Related Stocks: Gsk Plc ADR Pfizer Sarepta Therapeutics